Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 427125, 8 pages
http://dx.doi.org/10.1155/2015/427125
Review Article

Pathophysiological Role of Extracellular Purinergic Mediators in the Control of Intestinal Inflammation

Yosuke Kurashima,1,2,3 Hiroshi Kiyono,2,3,4 and Jun Kunisawa1,2,4,5,6

1Laboratory of Vaccine Materials, National Institute of Biomedical Innovation, Osaka 567-0085, Japan
2Division of Mucosal Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan
3Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, Tokyo 102-0075, Japan
4International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan
5Department of Microbiology and Immunology, Kobe University School of Medicine, Kobe 650-0017, Japan
6Graduate School of Pharmaceutical Sciences and Graduate School of Dentistry, Osaka University, Osaka 565-0871, Japan

Received 5 August 2014; Accepted 30 September 2014

Academic Editor: Ishak O. Tekin

Copyright © 2015 Yosuke Kurashima et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Idzko, D. Ferrari, and H. K. Eltzschig, “Nucleotide signalling during inflammation,” Nature, vol. 509, no. 7500, pp. 310–317, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Burnstock, “Purinergic signalling and disorders of the central nervous system,” Nature Reviews Drug Discovery, vol. 7, no. 7, pp. 575–590, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Burnstock, “The journey to establish purinergic signalling in the gut,” Neurogastroenterology and Motility, vol. 20, no. 1, pp. 8–19, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. A. Roberts, M. K. Lukewich, K. A. Sharkey, J. B. Furness, G. M. Mawe, and A. E. Lomax, “The roles of purinergic signaling during gastrointestinal inflammation,” Current Opinion in Pharmacology, vol. 12, no. 6, pp. 659–666, 2012. View at Publisher · View at Google Scholar
  5. W. G. Junger, “Immune cell regulation by autocrine purinergic signalling,” Nature Reviews Immunology, vol. 11, no. 3, pp. 201–212, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Piccini, S. Carta, S. Tassi, D. Lasiglié, G. Fossati, and A. Rubartelli, “ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1β and IL-18 secretion in an autocrine way,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 23, pp. 8067–8072, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. S. E. Adamson and N. Leitinger, “The role of pannexin1 in the induction and resolution of inflammation,” FEBS Letters, vol. 588, no. 8, pp. 1416–1422, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Iwase, H. Shinji, A. Tajima et al., “Isolation and identification of ATP-secreting bacteria from mice and humans,” Journal of Clinical Microbiology, vol. 48, no. 5, pp. 1949–1951, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Atarashi, J. Nishimura, T. Shima et al., “ATP drives lamina propria TH17 cell differentiation,” Nature, vol. 455, no. 7214, pp. 808–812, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Kusu, H. Kayama, M. Kinoshita et al., “Ecto-nucleoside triphosphate diphosphohydrolase 7 controls Th17 cell responses through regulation of luminal ATP in the small intestine,” Journal of Immunology, vol. 190, no. 2, pp. 774–783, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. H. K. Eltzschig, M. V. Sitkovsky, and S. C. Robson, “Purinergic signaling during inflammation,” The New England Journal of Medicine, vol. 367, no. 24, pp. 2322–2333, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. L.-H. Jiang, M. Kim, V. Spelta, X. Bo, A. Surprenant, and R. A. North, “Subunit arrangement in P2X receptors,” The Journal of Neuroscience, vol. 23, no. 26, pp. 8903–8910, 2003. View at Google Scholar · View at Scopus
  13. G. E. Torres, T. M. Egan, and M. M. Voigt, “Hetero-oligomeric assembly of P2X receptor subunits. Specificities exist with regard to possible partners,” The Journal of Biological Chemistry, vol. 274, no. 10, pp. 6653–6659, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. H. M. Costa-Junior, F. S. Vieira, and R. Coutinho-Silva, “C terminus of the P2X7 receptor: treasure hunting,” Purinergic Signalling, vol. 7, no. 1, pp. 7–19, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. H. L. Wilson, S. A. Wilson, A. Surprenant, and R. North, “Epithelial membrane proteins induce membrane blebbing and interact with the P2X7 receptor C terminus,” The Journal of Biological Chemistry, vol. 277, no. 37, pp. 34017–34023, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Scheuplein, N. Schwarz, S. Adriouch et al., “NAD+ and ATP released from injured cells induce P2X 7-dependent shedding of CD62L and externalization of phosphatidylserine by Murine T cells,” Journal of Immunology, vol. 182, no. 5, pp. 2898–2908, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Lin, S. Ren, L. Zhang, H. Jin, J. Sun, and Y. Zuo, “Extracellular ATP induces CD44 shedding from macrophage-like P388D1 cells via the P2X7 receptor,” Hematological Oncology, vol. 30, no. 2, pp. 70–75, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Chen, Y. Yao, Y. Sumi et al., “Purinergic signaling: a fundamental mechanism in neutrophil activation,” Science Signaling, vol. 3, no. 125, p. ra45, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Ferrari, P. Chiozzi, S. Falzoni, S. Hanau, and F. Di Virgilio, “Purinergic modulation of interleukin-1β release from microglial cells stimulated with bacterial endotoxin,” Journal of Experimental Medicine, vol. 185, no. 3, pp. 579–582, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Corrêa, C. Marques da Silva, A. C. de Abreu Moreira-Souza, R. C. Vommaro, and R. Coutinho-Silva, “Activation of the P2X7 receptor triggers the elimination of Toxoplasma gondii tachyzoites from infected macrophages,” Microbes and Infection, vol. 12, no. 6, pp. 497–504, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Darville, L. Welter-Stahl, C. Cruz, A. A. Sater, C. W. Andrews Jr., and D. M. Ojcius, “Effect of the purinergic receptor P2X7 on Chlamydia infection in cervical epithelial cells and vaginally infected mice,” The Journal of Immunology, vol. 179, no. 6, pp. 3707–3714, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Vono, M. Taccone, P. Caccin et al., “The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 52, pp. 21095–21100, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. J. K. Crane, R. A. Olson, H. M. Jones, and M. E. Duffey, “Release of ATP during host cell killing by enteropathogenic E. coli and its role as a secretory mediator,” American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 283, no. 1, pp. G74–G86, 2002. View at Google Scholar · View at Scopus
  24. J. K. Crane, T. M. Naeher, S. S. Choudhari, and E. M. Giroux, “Two pathways for ATP release from host cells in enteropathogenic Escherichia coli infection,” American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 289, no. 3, pp. G407–G417, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Puhar, H. Tronchère, B. Payrastre, G. Tran van Nhieu, and P. J. Sansonetti, “A Shigella effector dampens inflammation by regulating epithelial release of danger signal ATP through production of the lipid mediator PtdIns5P,” Immunity, vol. 39, no. 6, pp. 1121–1131, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Firon, M. Dinis, B. Raynal, C. Poyart, P. Trieu-Cuot, and P. A. Kaminski, “Extracellular nucleotide catabolism by the Group B Streptococcus ectonucleotidase NudP increases bacterial survival in blood,” The Journal of Biological Chemistry, vol. 289, no. 9, pp. 5479–5489, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Coutinho-Silva and D. M. Ojcius, “Role of extracellular nucleotides in the immune response against intracellular bacteria and protozoan parasites,” Microbes and Infection, vol. 14, no. 14, pp. 1271–1277, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Brumfield, J. J. Matasi, D. Tulshian et al., “Synthesis and SAR development of novel P2X7 receptor antagonists for the treatment of pain: part 2,” Bioorganic and Medicinal Chemistry Letters, vol. 21, no. 24, pp. 7287–7290, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Antonioli, R. Colucci, C. Pellegrini et al., “The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications,” Pharmacology & Therapeutics, vol. 139, no. 2, pp. 157–188, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Müller, B. Robaye, R. P. Vieira et al., “The purinergic receptor P2Y2 receptor mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation,” Allergy, vol. 65, no. 12, pp. 1545–1553, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Müller, R. P. Vieira, M. Grimm et al., “A potential role for P2X7R in allergic airway inflammation in mice and humans,” American Journal of Respiratory Cell and Molecular Biology, vol. 44, no. 4, pp. 456–464, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. D. M. Manthei, D. J. Jackson, M. D. Evans et al., “Protection from asthma in a high-risk birth cohort by attenuated P2X 7 function,” Journal of Allergy and Clinical Immunology, vol. 130, no. 2, pp. 496–502, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Wilhelm, J. Ganesan, T. Müller et al., “Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R,” Nature Medicine, vol. 16, no. 12, pp. 1434–1439, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Keating, P. Pelegrin, C. M. Martínez, and D. Grundy, “P2X7 receptor-dependent intestinal afferent hypersensitivity in a mouse model of postinfectious irritable bowel syndrome,” The Journal of Immunology, vol. 187, no. 3, pp. 1467–1474, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Thabane, D. T. Kottachchi, and J. K. Marshall, “Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome,” Alimentary Pharmacology & Therapeutics, vol. 26, no. 4, pp. 535–544, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Ohman and M. Simren, “Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions,” Nature Reviews Gastroenterology & Hepatology, vol. 7, no. 3, pp. 163–173, 2010. View at Google Scholar
  37. T. Weissmüller, E. L. Campbell, P. Rosenberger et al., “PMNs facilitate translocation of platelets across human and mouse epithelium and together alter fluid homeostasis via epithelial cell-expressed ecto-NTPDases,” Journal of Clinical Investigation, vol. 118, no. 11, pp. 3682–3692, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. U. Schenk, A. M. Westendorf, E. Radaelli et al., “Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels,” Science Signaling, vol. 1, no. 39, article ra6, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Degagné, J. Degrandmaison, D. M. Grbic, V. Vinette, G. Arguin, and F.-P. Gendron, “P2Y2 receptor promotes intestinal microtubule stabilization and mucosal re-epithelization in experimental colitis,” Journal of Cellular Physiology, vol. 228, no. 1, pp. 99–109, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. Kurashima, T. Amiya, T. Nochi et al., “Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors,” Nature Communications, vol. 3, article 1034, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. B. D. Gulbransen, M. Bashashati, S. A. Hirota et al., “Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis,” Nature Medicine, vol. 18, no. 4, pp. 600–604, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Yao, M. K. Levings, and T. S. Steiner, “ATP conditions intestinal epithelial cells to an inflammatory state that promotes components of DC maturation,” European Journal of Immunology, vol. 42, no. 12, pp. 3310–3321, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. C. C. Marques, M. T. Castelo-Branco, R. G. Pacheco et al., “Prophylactic systemic P2X7 receptor blockade prevents experimental colitis,” Biochimica et Biophysica Acta: Molecular Basis of Disease, vol. 1842, no. 1, pp. 65–78, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. A. R. Neves, M. T. L. Castelo-Branco, V. R. Figliuolo et al., “Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease,” Inflammatory Bowel Diseases, vol. 20, no. 3, pp. 444–457, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. H. K. Eltzschig, T. Eckle, A. Mager et al., “ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function,” Circulation Research, vol. 99, no. 10, pp. 1100–1108, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Kurashima, T. Amiya, K. Fujisawa et al., “The Enzyme Cyp26b1 mediates inhibition of mast cell activation by fibroblasts to maintain skin-barrier homeostasis,” Immunity, vol. 40, no. 4, pp. 530–541, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. D. J. Friedman, B. M. Künzli, Y. I. A-Rahim et al., “CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 39, pp. 16788–16793, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. M. S. Bynoe, A. T. Waickman, D. A. Mahamed, C. Mueller, J. H. Mills, and A. Czopik, “CD73 is critical for the resolution of murine colonic inflammation,” Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 260983, 13 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. N. A. Louis, A. M. Robinson, C. F. MacManus, J. Karhausen, M. Scully, and S. P. Colgan, “Control of IFN-αA by CD73: implications for mucosal inflammation,” The Journal of Immunology, vol. 180, no. 6, pp. 4246–4255, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. K. Synnestvedt, G. T. Furuta, K. M. Comerford et al., “Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia,” Journal of Clinical Investigation, vol. 110, no. 7, pp. 993–1002, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. S. P. Colgan and H. K. Eltzschig, “Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery,” Annual Review of Physiology, vol. 74, pp. 153–175, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. L. Antonioli, P. Pacher, E. S. Vizi, and G. Haskó, “CD39 and CD73 in immunity and inflammation,” Trends in Molecular Medicine, vol. 19, no. 6, pp. 355–367, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. L. Antonioli, R. Colucci, C. la Motta et al., “Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders,” Current Drug Targets, vol. 13, no. 6, pp. 842–862, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. J. H. Ye and V. M. Rajendran, “Adenosine: an immune modulator of inflammatory bowel diseases,” World Journal of Gastroenterology, vol. 15, no. 36, pp. 4491–4498, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Odashima, G. Bamias, J. Rivera-Nieves et al., “Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease,” Gastroenterology, vol. 129, no. 1, pp. 26–33, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. C. C. Kurtz, “Extracellular adenosine regulates colitis through effects on lymphoid and nonlymphoid cells,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 307, no. 3, pp. G338–G346, 2014. View at Google Scholar
  57. F. Ochoa-Cortes, A. Liñán-Rico, K. A. Jacobson, and F. L. Christofi, “Potential for developing purinergic drugs for gastrointestinal diseases,” Inflammatory Bowel Disease, vol. 20, no. 7, pp. 1259–1287, 2014. View at Google Scholar
  58. I. D. Mascanfroni, A. Yeste, S. M. Vieira et al., “IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39,” Nature Immunology, vol. 14, no. 10, pp. 1054–1063, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. T. Takahashi, Y. Kimura, K. Niwa et al., “In vivo imaging demonstrates ATP release from murine keratinocytes and its involvement in cutaneous inflammation after tape stripping,” Journal of Investigative Dermatology, vol. 133, no. 10, pp. 2407–2415, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. P. Pellegatti, L. Raffaghello, G. Bianchi, F. Piccardi, V. Pistoia, and F. Di Virgilio, “Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase,” PLoS ONE, vol. 3, no. 7, Article ID e2599, 2008. View at Publisher · View at Google Scholar · View at Scopus